COPART vs HBIO
COPART (COPART) versus Harvard Bioscience Inc (HBIO) — a side-by-side from cached financials, not a winner call.
COPART (COPART) common stock.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
COPART does not have a complete income-statement cache yet.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
HBIO currently screens at market cap $20.3M.
Not investment advice. Open the COPART and HBIO stock pages for the full models.
Not investment advice.